As much of the country charges forth with legalizing recreational marijuana, the drug continues to prove medically valuable. That's to say, science is still making discoveries about the active properties in the plant.
Recently a study of 127 patients concluded that active compounds in cannabis were more effective at reducing the frequency of migraines than prescription migraine medicine.
The study, whose findings were reported at the 3rd Congress of the European Academy of Neurology in Amsterdam, also showed that a 200mg dose of a THC-CBD drug every day for three months resulted in over 50% less pain.
A second phase of the study looked at migraines and cluster headaches, using the THC-CBD drug for some patients and a prescription drug commonly used to treat migraines for others. The results of this phase were again, significantly less pain with the CBD-THC compound (43.5%) and a slight reduction in frequency.
So, the next time a splitting headache comes, maybe it's best you reach for the pipe, not for the pillbox.